Abstract
Hypertrophic cardiomyopathy is a myocardial disorder with an autosomal pattern of inheritance characterized by an increased wall mass of a non-dilated left ventricle with heterogeneity in wall thickness and myocyte and myofibrillar disarray. Common symptoms are dyspnea, angina, fatigue and syncope. Patients with hypertrophic cardiomyopathy vary greatly in terms of the patterns and extent of left ventricular hypertrophy, ranging from localized subaortic hypertrophy to full-length septal involvement together with anterolateral wall extension.1 It is important to assess the degree of left ventricular hypertrophy in the individual patient since it may be a major determinant of symptoms and prognosis.2, 3 In hypertrophic cardiomyopathy regional wall thickness is directly associated with systolic4 and diastolic5 function. Correct anatomic classification of patients with hypertrophic cardiomyopathy is necessary for interpretation and understanding the results of studies with positron emission tomography.
Keywords
- Left Ventricular Hypertrophy
- Left Ventricular Mass
- Hypertrophic Cardiomyopathy
- Magnetic Resonance Imaging Measurement
- Wall Thickness Measurement
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418–428.
Wigle ED, Sasson Z, Henderson MA et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1–83.
Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophie cardiomyopathy. J Am Coll Cardiol 1990;15:1521–1526.
Dong SJ, MacGregor JH, Crawley AP et al. Left ventricular wall thickness and regional systolic function in patients with hypertrophie cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study. Circulation 1994;90:1200–1209.
Hayashida W, Kumada T, Kohno F et al. Left ventricular regional relaxation and its nonuniformity in hypertrophie nonobstructive cardiomyopathy. Circulation 1991;84:1496–1504.
Dinsmore RE. MRI determination of cardiac dimensions. In: Van der Wall EE, De Roos A, editors. Magnetic Resonance Imaging in Coronary Artery Disease. Dordrecht: Kluwer Academic Publishers, 1991:97–111.
AHA/ACC recommendation on tomographic imaging: standardization of cardiac tomographic imaging. An ACC/AHA policy statement. J Am Coll Cardiol 1992;20:255-256.
Dinsmore RE, Wismer GL, Levine RA, Okada RD, Brady TJ. Magnetic resonance imaging of the heart: position and gradient angle selection for optimal imaging planes. Am J Radiol 1984; 143:1135–1142.
Higgins CB, Byrd BF, Stark D et al. Magnetic resonance imaging in hypertrophie cardiomyopathy. Am J Cardiol 1985;55:1121–1126.
Been M, Kean D, Smith MA, Douglas RHB, Best JJK, Muir AL. Nuclear magnetic resonance in hypertrophie cardiomyopathy. Br Heart J 1985;54:48–52.
Sardanelli F, Molinari G, Petillo A et al. MRI in hypertrophie cardiomyopathy: a morphofunctional study. J Comput Assist Tomogr 1993; 17:862–872.
Park JH, Kim YM, Chung JW, Park YB, Han JK, Han MC. MR imaging of hypertrophie cardiomyopathy. Radiology 1992; 185:441–416.
Allison JD, Flickinger FW, Wright JC et al. Measurement of left ventricular mass in hypertrophie cardiomyopathy using MRI: comparison with echocardiography. Magn Reson Imaging 1993;11:329–334.
Maron BJ, Epstein SE. Hypertrophie cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43:1242–1244.
Hamer JPM. Practical echocardiography in the adult with Doppler and color-Doppler flow imaging. Dordrecht: Kluwer Academic Publishers, 1990:10.
Vacek JL, Davis WR, Bellinger RL, McKieman TL. Apical hypertrophie cardiomyopathy in American patients. Am Heart J 1984; 108:1501–1506.
Casolo GC, Trotta F, Rostagno C et al. Detection of apical hypertrophie cardiomyopathy by magnetic resonance imaging. Am Heart J 1989; 117:468–472.
Suzuki J, Watanabe F, Takenaka K et al. New subtype of apical hypertrophie cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T waves. J Am Coll Cardiol 1993;22:1175–1181.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Posma, J.L., Blanksma, P.K., Lie, K.I. (1995). Classification of Hypertrophic Cardiomyopathy with Magnetic Resonance Imaging Compared with Echocardiography. In: van der Wall, E.E., Blanksma, P.K., Niemeyer, M.G., Paans, A.M.J. (eds) Cardiac Positron Emission Tomography. Developments in Cardiovascular Medicine, vol 166. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0023-6_11
Download citation
DOI: https://doi.org/10.1007/978-94-011-0023-6_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4014-3
Online ISBN: 978-94-011-0023-6
eBook Packages: Springer Book Archive